An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population

Human Genetics

Volumn 127, Issue 1, 2010, Pages 75-81

  Gu, Xing ^a   Qi , Peng ^a   Zhou, Feiguo ^a   Ji, Qiang ^a   Wang, Hao ^b   Dou, Tonghai ^c   Zhao, Yunpeng ^a   Gao, Chunfang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

CRHR2; HBV related HCC; SNP; Susceptibility

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYTOSINE; THYMINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 2;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INTRON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN; CHINA; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RISK; RISK FACTOR;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HUMANS; INTRONS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RISK FACTORS; YOUNG ADULT;

EID: 77449128409     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-009-0750-6     Document Type: Article

References (40)

1. Arcuri F, Cintorino M, Florio P et al (2002) Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma. Prostate 52:167-172
2. Bale TL, Contarino A, Smith GW et al (2000) Mice deWcient for corticotropin- releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414
3. Bale TL, Giordano FJ, Hickey RP et al (2002) Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 99:7734-7739
4. Bale TL, Giordano FJ, Vale WW (2003) A new role for corticotropinreleasing factor receptor-2: suppression of vascularization. Trends Cardiovasc Med 13:68-71
5. Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2:1129-1133
6. Block TM, Mehta AS, Fimmel CJ, Jordan R (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22:5093-5107
7. Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW (2003) Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identiWcation of multiple splice variants. Mol Endocrinol 17:395-410
8. Chatzaki E, Euthymiadi C, Kyriaki S et al (2005) Urocortin and corticotropin- releasing hormone receptor type 2 expression in the human gallbladder. Neuroendocrinology 82:177-184
9. Coste SC, Kesterson RA, Heldwein KA et al (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin- releasing hormone receptor-2. Nat Genet 24:403-409
10. De Luca V, Tharmalingam S, Kennedy JL (2007) Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry 22:282-287 (Pubitemid 47088197)
11. Dickinson JA, Wun YT, Wong SL (2002) Modelling death rates for carriers of hepatitis B. Epidemiol Infect 128:83-92
12. Florio P, De Falco G, Leucci E et al (2006) UCN expression is downregulated in human endometrial carcinoma. J Endocrinol 190:99-105
13. Hoare SRJ, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE (2005) Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 26:457-470
14. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP (1991) Autocrine or paracrine inXammatory actions of corticotropin- releasing hormone in vivo. Science 254:421-423
15. Kato N, Ji G, Wang Y et al (2005) Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 42:846-853
16. Kim YJ, Lee HS (2005) Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 48:10-15
17. Kimura Y, Takahashi K, Totsune K et al (2002) Expression of UCN and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340-346
18. Kishimoto T, Pearse RV 2nd, Lin CR, Rosenfeld MG (1995) A sauvagine/ corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 2:1108-1112
19. Kishimoto T, Radulovic J, Radulovic M et al (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24:415-419
20. Kokkotou E, Torres D, Moss AC et al (2006) Corticotropin-releasing hormone receptor 2-deWcient mice have reduced intestinal inXammatory responses. J Immunol 177:3355-3361
21. Kostich WA, Chen A, Sperle K, Largent BL (1998) Molecular identi- Wcation and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2 receptor. Mol Endocrinol 12:1077-1085
22. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, De Souza EB (1996) Cloning and characterization of the human corticotropin releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77
23. Lovenberg TW, Chalmers DT, Liu C, De Souza EB (1995) CRF2 and CRF2 receptor mRNAs are diVerentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142
24. Meyer AH, Ullmer C, Schmuck K et al (1997) Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis. Genomics 40:189-190
25. Moss AC, Anton P, Savidge T et al (2007) Urocortin II mediates proinXammatory eVects in human colonocytes via corticotropinreleasing hormone receptor 2alpha. Gut 56:1210-1217
26. Murakami Y, Mori T, Koshimura K et al (1997) Stimulation by urocortin of growth hormone (GH) secretion in GH-producing human pituitary adenoma cells. Endocr J 44:627-629
27. Muramatsu Y, Sugino N, Suzuki T et al (2001) UCN and corticotropin releasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab 86:1362-1369
28. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4-S66
29. Popper H, Gerber MA, Thung SN (1982) The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology 2:1S-9S
30. Qi P, Chen YM, Wang H et al (2009) -509C> T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Cancer Immunol Immunother 58(9):1433-1440
31. Reubi JC, Waser B, Vale W, Rivier J (2003) Expression of CRF1 and CRF2 receptors in human cancers. J Clin Endocrinol Metab 88:3312-3320
32. Robinson WS (1995) Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice ofinfectious diseases, 4th edn. Churchill Livingstone, New York, pp 1406-1439
33. Tezval H, Jurk S, Atschekzei F, Serth J, Kuczyk MA, Merseburger AS (2009) The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of antiangiogenic signaling pathways. Prostate 69:443-448
34. Tochigi M, Kato C, Otowa T et al (2006) Association between corticotropin-releasing hormone receptor 2 (CRHR2) gene polymorphism and personality traits. Psychiatry Clin Neurosci 60:524-526 (Pubitemid 44060813)
35. Van Pett K, Viau V, Bittencourt JC et al (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212
36. Vaughan J, Donaldson C, Bittencourt J et al (1995) Urocortin, a mammalian neuropeptide related to Wsh urotensin I and to corticotropin- releasing factor. Nature 378:287-292
37. Villafuerte SM, Del-Favero J, Adolfsson R et al (2002) Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am J Med Genet 114:222-226
38. Wang JJ, Li SN (2007) Corticotropin-releasing factor family and its receptors: tumor therapeutic targets? Biochem Biophys Res Commun 362:785-788
39. Wang JJ, Xu YH, Xu YY et al (2008) Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin- releasing factor receptor 2. Cancer Investig 26:359-368
40. Yoshida H, Shiratori Y, Moriyama M et al (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med 131:174-181